GlassScriptPhysician profile
Sirin Pandey
NPI 1194955716
$676.87
in general payments reported to CMS, 2019-2025
20 companies · $313 in 2025
The $313 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $183 · 2020: $29.18 · 2023: $16.37 · 2024: $135 · 2025: $313.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $123.12 | 2024-2025 | Minimed 780g, Guardian Sensor (3) |
| Insulet Corporation | $74.79 | 2025 | Omnipod |
| Dexcom, INC. | $56.37 | 2023-2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $51.44 | 2019-2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.34 | 2019 | |
| Lilly USA, LLC | $34.59 | 2019 | |
| Becton, Dickinson and Company | $33.44 | 2019 | |
| Sanofi-Aventis U.S. LLC | $32.01 | 2019 | |
| Novartis Pharmaceuticals Corporation | $27.08 | 2024 | |
| Abbvie INC. | $26.79 | 2019-2020 | |
| Abbott Laboratories | $21.83 | 2025 | Freestyle Libre 3 |
| Ucb, INC. | $21.35 | 2025 | Rystiggo |
| Radius Health, INC. | $20.66 | 2025 | |
| Sequel Med Tech, LLC | $19.47 | 2025 | Twiist |
| Tandem Diabetes Care, INC. | $18.55 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ascendis Pharma Endocrinology INC | $18.51 | 2025 | Yorvipath |
| Ibsa Pharma INC. | $17.89 | 2025 | Tirosint, Flector, Licart |
| Janssen Pharmaceuticals, INC | $15.62 | 2020 | |
| Antares Pharma, INC. | $14.55 | 2019 | |
| Cequr Corporation | $12.47 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sirin Pandey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.